Renishaw plc (RNSHF)
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist Renishaw plc (RNSHF) ein Technology-Unternehmen mit einer Bewertung von 0. Die Aktie erzielt 54/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 16. März 2026Renishaw plc (RNSHF) Technologieprofil & Wettbewerbsposition
Renishaw plc, a UK-based engineering and scientific technology firm, delivers metrology and healthcare solutions worldwide. With a focus on precision measurement and process control, Renishaw serves diverse sectors including aerospace, automotive, and healthcare, leveraging its innovative product portfolio and global distribution network to maintain a competitive edge.
Investmentthese
Renishaw presents a compelling investment case based on its diverse product portfolio and global market reach. With a P/E ratio of 37.88 and a profit margin of 10.1%, the company demonstrates solid financial performance. The dividend yield of 2.02% provides an additional incentive for investors. Key growth drivers include expanding applications of additive manufacturing and increasing demand for precision measurement in various industries. However, potential risks include economic downturns affecting capital expenditures and competition from other technology providers. The company's beta of 0.87 suggests lower volatility compared to the overall market.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $4.29 billion, reflecting a significant presence in the technology sector.
- Gross margin of 52.1%, indicating strong pricing power and efficient cost management.
- Dividend yield of 2.02%, offering a steady income stream for investors.
- Profit margin of 10.1%, showcasing profitability in a competitive market.
- Beta of 0.87, suggesting lower volatility compared to the broader market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Strong technological expertise in metrology and healthcare.
- Diverse product portfolio serving multiple industries.
- Global distribution and service network.
- Reputation for quality and precision.
Schwaechen
- Dependence on capital expenditures in cyclical industries.
- Exposure to currency fluctuations.
- Limited presence in certain emerging markets.
- Relatively high P/E ratio compared to some competitors.
Katalysatoren
- Upcoming: Launch of new additive manufacturing systems in Q4 2026, targeting the aerospace and automotive industries.
- Ongoing: Increasing adoption of Renishaw's healthcare products, particularly neurosurgical robots, in hospitals worldwide.
- Ongoing: Expansion of metrology solutions in emerging markets, driven by growing manufacturing sectors.
- Upcoming: Strategic partnerships with technology companies to enhance product offerings in Q2 2027.
- Ongoing: Continued investment in research and development to drive innovation and maintain competitive edge.
Risiken
- Potential: Economic downturns affecting capital expenditures in key industries.
- Ongoing: Competition from other technology providers in metrology and healthcare.
- Potential: Disruptive technologies rendering existing products obsolete.
- Ongoing: Exposure to currency fluctuations impacting financial results.
- Potential: Regulatory changes in healthcare and manufacturing affecting product approvals and market access.
Wachstumschancen
- Expansion in Additive Manufacturing: Renishaw can capitalize on the growing additive manufacturing market, projected to reach $55.8 billion by 2027. By developing advanced additive manufacturing systems and materials, Renishaw can serve industries such as aerospace and healthcare, offering customized solutions and gaining a competitive edge. This expansion requires continued investment in research and development and strategic partnerships.
- Penetration of Healthcare Market: The healthcare market presents a significant growth opportunity for Renishaw, particularly in neurosurgical robotics and customized implants. As the demand for precision medicine and minimally invasive procedures increases, Renishaw's innovative healthcare products can gain wider adoption. The global neurosurgical robotics market is expected to reach $2.5 billion by 2028, providing a substantial market for Renishaw's products.
- Advancements in Metrology Solutions: Renishaw can leverage its expertise in metrology to develop advanced measurement and inspection solutions for various industries. The increasing demand for precision and quality control in manufacturing drives the need for innovative metrology products. The global metrology market is expected to reach $14.5 billion by 2025, offering a significant opportunity for Renishaw to expand its market share.
- Geographic Expansion in Emerging Markets: Emerging markets, such as Asia-Pacific and Latin America, offer significant growth potential for Renishaw. By establishing a stronger presence in these regions and tailoring products to local needs, Renishaw can tap into new customer bases and increase revenue. The growth in manufacturing and healthcare sectors in these regions will drive demand for Renishaw's products and services.
- Strategic Partnerships and Acquisitions: Renishaw can pursue strategic partnerships and acquisitions to expand its product portfolio and market reach. Collaborating with other technology companies and acquiring complementary businesses can enhance Renishaw's capabilities and strengthen its competitive position. These partnerships can provide access to new technologies, markets, and customers, accelerating Renishaw's growth.
Chancen
- Expansion in additive manufacturing market.
- Penetration of healthcare market with innovative products.
- Geographic expansion in emerging markets.
- Strategic partnerships and acquisitions.
Risiken
- Economic downturns affecting capital spending.
- Competition from other technology providers.
- Disruptive technologies.
- Regulatory changes in healthcare and manufacturing.
Wettbewerbsvorteile
- Technological expertise in metrology and additive manufacturing.
- Strong brand reputation for quality and precision.
- Global distribution and service network.
- Proprietary technology and intellectual property.
- Diverse product portfolio serving multiple industries.
Ueber RNSHF
Renishaw plc, founded in 1973 and headquartered in Wotton-under-Edge, United Kingdom, is an engineering and scientific technology company with a global presence. The company designs, manufactures, distributes, sells, and services a range of metrology and healthcare products. Its metrology offerings include co-ordinate measuring machine (CMM) products, machine tool probe and software, performance measurement systems, gauging systems, fixtures, and styli for touch probe systems. Additionally, Renishaw provides interferometric laser, magnetic, and optical encoders, additive manufacturing systems, and vacuum casting machines. In the healthcare sector, Renishaw offers dental scanners, neurosurgical robots and accessories, neurosurgical planning software, drug delivery systems, Raman microscopes, craniomaxillofacial customized implants, analysers, and hybrid Raman systems. The company also provides asset financing and travel agency services. Renishaw serves a wide array of industries, including aerospace, agriculture, automotive, construction, consumer electronics, healthcare, power generation, resource exploration, energy, heavy industry, medical, and precision manufacturing, as well as scientific, research, and analysis sectors. Renishaw's commitment to innovation and precision has established it as a key player in the global technology landscape.
Was das Unternehmen tut
- Designs and manufactures metrology products, including CMMs and machine tool probes.
- Develops and distributes healthcare products, such as dental scanners and neurosurgical robots.
- Offers additive manufacturing systems for various industries.
- Provides encoders for motion control applications.
- Supplies Raman microscopes for scientific research and analysis.
- Offers customized implants for craniomaxillofacial surgery.
- Provides asset financing and travel agency services.
Geschaeftsmodell
- Sales of metrology products and systems to manufacturing industries.
- Revenue from healthcare product sales, including dental scanners and surgical robots.
- Income from additive manufacturing systems and related services.
- Service and maintenance contracts for installed equipment.
- Asset financing and travel agency services.
Branchenkontext
Renishaw operates in the hardware, equipment, and parts industry within the broader technology sector. The industry is characterized by continuous innovation and increasing demand for precision and automation. Market trends include the adoption of additive manufacturing, advancements in metrology, and the integration of technology in healthcare. Renishaw competes with companies like APELY (Applied Materials Inc.) and ASUUY (ASML Holding NV), focusing on niche markets and specialized solutions. The global market for precision measurement and additive manufacturing is expected to grow, driven by demand from industries like aerospace and healthcare.
Wichtige Kunden
- Aerospace industry for precision measurement and manufacturing.
- Automotive industry for quality control and automation.
- Healthcare sector for dental and surgical applications.
- Consumer electronics industry for precision manufacturing.
- Research and scientific institutions for analysis and measurement.
Finanzdaten
Chart & Info
Renishaw plc (RNSHF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Stocks That Hit 52-Week Lows On Thursday
· 27. Feb. 2020
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer RNSHF.
Kursziele
Wall-Street-Kurszielanalyse fuer RNSHF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von RNSHF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Klassifizierung
Branche Hardware, Equipment & PartsFuehrung: William Ernest Lee
Chief Executive Officer
William Ernest Lee serves as the Chief Executive Officer of Renishaw plc. His background includes extensive experience in the engineering and technology sectors. Prior to his role at Renishaw, he held various leadership positions in technology-driven companies, focusing on strategic development and operational efficiency. He is known for his expertise in driving innovation and expanding market presence. Lee's educational background includes advanced degrees in engineering and business management, providing him with a strong foundation for leading a global technology company.
Erfolgsbilanz: Under William Ernest Lee's leadership, Renishaw has focused on expanding its presence in key markets and investing in research and development. Key achievements include the launch of innovative products in the healthcare and additive manufacturing sectors. He has also overseen strategic acquisitions and partnerships to enhance Renishaw's capabilities and market reach. His tenure has been marked by a commitment to technological innovation and sustainable growth.
RNSHF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Renishaw plc (RNSHF) may have limited financial disclosure and regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Companies in this tier may not meet the minimum listing requirements of higher-tier OTC markets or national exchanges. Investing in OTC Other stocks involves higher risks due to the potential lack of transparency and regulatory scrutiny. Investors should conduct thorough due diligence before considering an investment in RNSHF.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure and transparency.
- Lower liquidity and trading volumes.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Obtain and review available financial statements.
- Assess the company's management team and track record.
- Research the company's industry and competitive landscape.
- Evaluate the company's business model and revenue streams.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established operating history in the engineering and scientific technology sector.
- Global presence and diverse product portfolio.
- Reputation for quality and innovation.
- Presence of a recognized CEO and management team.
- Dividend payments indicating financial stability.
Renishaw plc Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for RNSHF?
Renishaw plc (RNSHF) currently holds an AI score of 54/100, indicating moderate score. Key strength: Strong technological expertise in metrology and healthcare.. Primary risk to monitor: Potential: Economic downturns affecting capital expenditures in key industries.. This is not financial advice.
How frequently does RNSHF data refresh on this page?
RNSHF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven RNSHF's recent stock price performance?
Recent price movement in Renishaw plc (RNSHF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong technological expertise in metrology and healthcare.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider RNSHF overvalued or undervalued right now?
Determining whether Renishaw plc (RNSHF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying RNSHF?
Before investing in Renishaw plc (RNSHF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding RNSHF to a portfolio?
Potential reasons to consider Renishaw plc (RNSHF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Strong technological expertise in metrology and healthcare.. Additionally: Diverse product portfolio serving multiple industries.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of RNSHF?
Yes, most major brokerages offer fractional shares of Renishaw plc (RNSHF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track RNSHF's earnings and financial reports?
Renishaw plc (RNSHF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for RNSHF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on available information and may be subject to change.
- OTC market data may have limited accuracy and availability.
- AI analysis is pending and may provide further insights.